Compare GNLN & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLN | HKPD |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Durable Goods | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 10.6M |
| IPO Year | 2019 | 2025 |
| Metric | GNLN | HKPD |
|---|---|---|
| Price | $1.56 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 94.5K | 48.6K |
| Earning Date | 11-14-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,653,000.00 | ★ $20,313,818.00 |
| Revenue This Year | $1,541.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $1.50 | $0.68 |
| 52 Week High | $1,315.61 | $3.79 |
| Indicator | GNLN | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 21.66 | 42.93 |
| Support Level | $1.52 | $0.75 |
| Resistance Level | $1.77 | $0.90 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 3.58 | 45.45 |
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.